The novel non‐steroidal MR antagonist finerenone improves metabolic parameters in high‐fat diet‐fed mice and activates brown adipose tissue via AMPK‐ATGL pathway-Reference-Cited by-同舟云学术

The novel non‐steroidal MR antagonist finerenone improves metabolic parameters in high‐fat diet‐fed mice and activates brown adipose tissue via AMPK‐ATGL pathway

Published:2020-07-30 Issue:9 Volume:34 Page:12450-12465
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Marzolla Vincenzo¹,Feraco Alessandra¹,Gorini Stefania¹,Mammi Caterina¹,Marrese Carmen¹,Mularoni Valentina²,Boitani Carla²,Lombès Marc³,Kolkhof Peter⁴,Ciriolo Maria Rosa⁵⁶,Armani Andrea¹⁷,Caprio Massimiliano¹⁷

Affiliation:

1. Laboratory of Cardiovascular Endocrinology IRCCS San Raffaele Pisana Rome Italy

2. Department of Anatomical, Histological, Forensic and Orthopedic Sciences ‐ Section of Histology and Medical Embryology Sapienza University of Rome Rome Italy

3. INSERM UMR_S U1185, Fac Med Paris Sud, Univ. Paris SudUniversité Paris‐Saclay, Le Kremlin Bicêtre Orsay France

4. Bayer AG, R&D Preclinical Research Cardiovascular Wuppertal Germany

5. Department of Biology University of Rome “Tor Vergata” Rome Italy

6. IRCCS San Raffaele Pisana Rome Italy

7. Department of Human Sciences and Promotion of the Quality of Life San Raffaele Roma Open University Rome Italy

Funder

Agenzia Italiana del Farmaco, Ministero della Salute

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology